Login / Signup

Adiponectin: A Predictor for Breast Cancer Survival?

Hikmet Erhan GüvenLutfi DoganMehmet Ali GülçelikNeşe Ersöz Gülçelik
Published in: European journal of breast health (2018)
Preoperative adiponectin levels may be useful to predict survival rates in breast cancer or may be used as a marker/predictor for defining patients who require more aggressive treatment. In order for adiponectin to be used as a practical clinical marker for breast cancer, large database studies are should be conducted.
Keyphrases
  • metabolic syndrome
  • insulin resistance
  • emergency department
  • type diabetes
  • adipose tissue
  • skeletal muscle
  • young adults
  • adverse drug
  • drug induced